Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis

1. Gomez-Veiga, F.
2. Szmulewitz, R.Z.
3. Holzbeierlein, J.
4. Azad, A.A.
5. Iguchi, T.
6. Villers, A.
7. Alcaraz, A.
8. Alekseev, B.
9. Shore, N.D.
10. Rosbrook, B.
11. Zohren, F.
12. Ma, J.
13. Haas, G.P.
14. Stenzl, A.
15. Armstrong, A.J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.EUO.2023.11.012 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus